Montes Archimedes Acquisition Corp. (NASDAQ:MAAC) announced that it experienced high redemptions, but secured shareholder approval of its combination with biotech firm Roivant Sciences at a special meeting yesterday.
A total of 38,400,312 shares, representing about 93.5% of all outstanding shares, were redeemed in connection with the vote leaving approximately 2,671,508 public SPAC shares and roughly $26.7 million remaining in trust. As a result, Roivant has waived its $210 million minimum cash condition. The deal is nonetheless expected to close tomorrow, September 30, and the combined company’s shares are set to trade on the Nasdaq soon thereafter under the symbol “ROIV”.
The deal included a $200 million PIPE at announcement and the public listing will still provide M&A flexibility for Roivant, which has announced a number of transactions since its deal with Montes Archimedes. Roivant expects to receive $320 million in cash and cash equivalents as a part of the merger of it subsidiary Datavant with Ciox Health and a further $100 million from SK’s investment in another subsidiary, Proteovant.
Montes Archimedes originally announced its $5 billion deal with Roivant on May 3. Basel, Switzerland-based Roivant develops an array of drug candidates acquired from peers or internally developed with its enhanced computing platform.
Only one other proposal was placed on the ballot of the special meeting. Both it and the business combination were passed by wide margins. Full vote tallies and descriptions of the measures may be found HERE.
ADVISORS
- J.P. Morgan Securities LLC is serving as a financial advisor and capital markets advisor to Roivant and as a lead placement agent for the PIPE.
- SVB Leerink LLC is serving as a capital markets advisor to Roivant and as a lead placement agent for the PIPE.
- Goldman Sachs & Co. LLC is serving as a financial advisor to Roivant.
- Cowen and Company, LLC is serving as a financial advisor and capital markets advisor to Roivant.
- Citigroup Global Markets Inc. is serving as a placement agent for the PIPE.
- Truist Securities, Inc. is serving as a capital markets advisor to Roivant and as a placement agent for the PIPE.
- Davis Polk & Wardwell LLP is acting as legal counsel to Roivant.
- Kirkland & Ellis LLP is acting as legal counsel to MAAC.
At the SPAC of Dawn The results are in for the first of yesterdays’ two big completion votes, and it appears set to finish with one of the best redemption results of any completion vote over the last two years. Only two SPACs have gotten all the way through their de-SPACing process since January 1,...
Rare earth miner Critical Metals (NASDAQ:CRML) dropped a new presentation today, providing its most significant update since completing its combination with Sizzle in February. The document points to 2024 being a potentially pivotal year for the firm as it cleared major development hurdles in getting preparing the ground for its Wolfberg lithium mine in Austria,...
At the SPAC of Dawn Today is the busiest day for SPACs in at least a month as three SPACs will hold extension votes and three more are seeking deal approval. Those completion votes will each bear watching and they include two of the most prominent deals of the past six months. Screaming Eagle (NASDAQ:SCRM)...
Some renewed hope around a 2024 rate cut propelled several stocks skyward in late Monday trading, and a large number of the day’s biggest gainers are tech-focused recent de-SPACs. The biggest one-day gain among de-SPACs late in the trading day is the +51.4% held by software firm XBP Europe (NASDAQ:XBP), which spun out from Exela...
Metals Acquisition (NYSE:MTAL) has begun an exchange of all outstanding warrants, offering holders up to 0.361 shares per warrant on a cashless basis or $0.10 per warrant if they so choose. The cashless option provides significantly more value as Metals last closed at $12.85, meaning warrants converted under that ratio would be worth about $4.63...